Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Atrial Fibrillation
- Elderly
- Renal Insufficiency
- Rivaroxaban
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 65 years and 125 years
- Gender
- Both males and females
Description
Study Population Elderly patients with age ? 65 years with treatment naïve or treatment-experienced patients who are diagnosed with NVAF Expected number of patient enrollment is about 1200 patients, Samsung Medical Center is aim to enroll about 200 patients
Study Population Elderly patients with age ? 65 years with treatment naïve or treatment-experienced patients who are diagnosed with NVAF Expected number of patient enrollment is about 1200 patients, Samsung Medical Center is aim to enroll about 200 patients
Tracking Information
- NCT #
- NCT04096547
- Collaborators
- Bayer
- Investigators
- Not Provided